Ditropan
Product Images NDC 54868-4610

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ditropan (NDC 54868-4610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (10 mg bottle)

Ditropan XL 10 mg extended release tablets packaging label by Physicians Total Care, Inc. The label shows 30 tablets per bottle with the active ingredient oxybutynin chloride. It includes dosage strength, caution statement about prescription dispensing, lot and expiration details, refill information, and storage instructions.*

FDA Label Image

Principal Display Panel (15 mg bottle)

Ditropan XL 15 mg extended release tablets label by Physicians Total Care, Inc. The label indicates a quantity of 30 tablets containing oxybutynin chloride. It includes caution about federal law prohibiting dispensing without prescription and provides dosage and storage instructions along with a lot number and expiration date.*

FDA Label Image

Chemical Structure (Ditropan 01)

Chemical structure of the active ingredient shown in association with Ditropan XL, indicated by the molecular diagram featuring benzene rings and functional groups with a hydrochloride salt.*

FDA Label Image

Figure 1 (Ditropan 02)

A pharmacokinetic chart depicting mean plasma ROxybutynin concentration (ng/mL) over 24 hours post-dose. The line graph compares Ditropan XL 36 mg once daily with oxybutynin 5 mg three times daily (TID), showing concentration fluctuations at various time points from 0 to 24 hours.*

FDA Label Image

Figure 2 (Ditropan 03)

A line graph showing mean R-Oxybutynin plasma concentration (ng/ml) over time (hours). The graph displays data points at various times up to 24 hours, indicating plasma concentration changes with error bars representing variability.*

FDA Label Image

Figure 3 (Ditropan 04)

A data table titled 'Number of Urge Urinary Incontinence Episodes Per Week' comparing Ditropan XL to placebo and oxybutynin across three studies. The table presents mean baseline values, mean changes from baseline with standard deviations, and 95% confidence intervals for differences in urge urinary incontinence episodes per week between Ditropan XL and comparators. Adjacent to each study are forest plots illustrating these differences graphically.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.